227 related articles for article (PubMed ID: 2975631)
1. Sustained impairment of pituitary and testicular function in prostatic cancer patients treated with a depot form of a GnRH agonist.
Rolandi E; Franceschini R; Giberti C; Brancadoro T; Martorana G; Barreca T
Horm Res; 1988; 30(1):22-5. PubMed ID: 2975631
[TBL] [Abstract][Full Text] [Related]
2. [Decapeptyl (D-Trp6-LH-RH) in the therapy of prostatic cancer with reference to the intramuscular administration of a depot preparation].
Seppelt U; Bertermann H; Saerbeck C
Urologe A; 1986 Sep; 25(5):298-301. PubMed ID: 2947371
[TBL] [Abstract][Full Text] [Related]
3. Hormonal pattern and testicular histology in patients with prostatic cancer after long-term treatment with a gonadotropin-releasing hormone agonist analogue.
Giberti C; Barreca T; Martorana G; Truini M; Franceschini R; Rolandi E; Giuliani L
Eur Urol; 1988; 15(1-2):125-7. PubMed ID: 2975220
[TBL] [Abstract][Full Text] [Related]
4. Long-term results with a long-acting formulation of D-TRP-6 LH-RH in patients with prostate cancer: an Italian prostatic cancer project (P.O.N.CA.P.) study.
Boccardo F; Decensi A; Guarneri D; Rubagotti A; Massa T; Martorana G; Giberti C; Cerruti GB; Tani F; Zanollo A
Prostate; 1987; 11(3):243-55. PubMed ID: 2960957
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics, endocrine and antitumour effects of leuprolide depot (TAP-144-SR) in advanced prostatic cancer: a dose-response evaluation.
Mazzei T; Mini E; Eandi M; Reali EF; Fioretto L; Bartoletti R; Rizzo M; Calabrò G; Periti P
Drugs Exp Clin Res; 1989; 15(8):373-87. PubMed ID: 2513176
[TBL] [Abstract][Full Text] [Related]
6. Endocrine effects of combined treatment with an LHRH agonist in association with flutamide in metastatic prostatic carcinoma.
Bélanger A; Labrie F; Dupont A; Brochu M; Cusan L
Clin Invest Med; 1988 Oct; 11(5):321-6. PubMed ID: 2972431
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of prostatic cancer with slow-release formulation of luteinizing hormone releasing hormone (LH-RH) analog].
Fuse H; Akimoto S; Akakura K; Shimazaki J; Murakami S
Hinyokika Kiyo; 1988 Mar; 34(3):555-60. PubMed ID: 3133936
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the pituitary-gonadal axis by a single intramuscular administration of D-Trp-6-LH-RH (decapeptyl) in a sustained-release formulation in patients with prostatic carcinoma.
Gonzalez-Barcena D; Perez-Sanchez PL; Graef A; Gomez AM; Berea H; Comaru-Schally AM; Schally AV
Prostate; 1989; 14(4):291-300. PubMed ID: 2526325
[TBL] [Abstract][Full Text] [Related]
9. Treatment of prostatic cancer with a depot form of a luteinizing hormone-releasing hormone analogue.
Giuliani L; Barreca T; Giberti C; Franceschini R; Martorana G; Brancadoro MT; Salvemini M; Rolandi E
Eur Urol; 1986; 12(6):390-4. PubMed ID: 2949979
[TBL] [Abstract][Full Text] [Related]
10. Individual variation of hormonal recovery after cessation of luteinizing hormone-releasing hormone agonist therapy in men receiving long-term medical castration therapy for prostate cancer.
Kobayashi T; Nishizawa K; Mitsumori K
Scand J Urol Nephrol; 2006; 40(3):198-203. PubMed ID: 16809259
[TBL] [Abstract][Full Text] [Related]
11. Prolactin and pituitary gonadotropin values and responses to acute luteinizing hormone-releasing hormone (LHRH) challenge in patients having long-term treatment with a depot LHRH analogue.
Mahler C; Verhelst J; Chaban M; Denis L
Cancer; 1991 Feb; 67(3):557-9. PubMed ID: 1824680
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of prostatic cancers by periodic administration of a delayed-release preparation of D-Trp(6)-LHRH].
Roger M; Duchier J; Lahlou N; Schally AV
Ann Urol (Paris); 1986; 20(2):109-12. PubMed ID: 2424359
[TBL] [Abstract][Full Text] [Related]
13. The sustained release of LH X RH agonist from LH X RH agonist-polymer composite in patients with prostatic cancer.
Imai K; Yamanaka H; Yuasa H; Yoshida M; Asano M; Kaetu I; Yamazaki I; Suzuki K
Prostate; 1986; 8(4):325-32. PubMed ID: 3086853
[TBL] [Abstract][Full Text] [Related]
14. Response to D-Trp-6-luteinising hormone releasing hormone (Decapeptyl) microcapsules in advanced ovarian cancer.
Parmar H; Rustin G; Lightman SL; Phillips RH; Hanham IW; Schally AV
Br Med J (Clin Res Ed); 1988 Apr; 296(6631):1229. PubMed ID: 2968130
[No Abstract] [Full Text] [Related]
15. Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in the human male. III. Effects of long term combined treatment with GnRH agonist and androgen.
Bhasin S; Heber D; Steiner BS; Handelsman DJ; Swerdloff RS
J Clin Endocrinol Metab; 1985 May; 60(5):998-1003. PubMed ID: 3920237
[TBL] [Abstract][Full Text] [Related]
16. Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules.
Roger M; Chaussain JL; Berlier P; Bost M; Canlorbe P; Colle M; Francois R; Garandeau P; Lahlou N; Morel Y
J Clin Endocrinol Metab; 1986 Apr; 62(4):670-7. PubMed ID: 2936759
[TBL] [Abstract][Full Text] [Related]
17. [Clinical phase I and phase II study on a sustained release formulation of leuprorelin acetate (TAP-144-SR), an LH-RH agonist, in patients with prostatic carcinoma. Collaborative++ Studies on Prostatic Carcinoma by the Study Group for TAP-144-SR].
Niijima T; Aso Y; Akaza H; Fujita K; Fuse H; Hosaka M; Isurugi K; Kamidono S; Katayama T; Kawabe K
Hinyokika Kiyo; 1990 Nov; 36(11):1343-60. PubMed ID: 2126912
[TBL] [Abstract][Full Text] [Related]
18. Effects of a long-acting LHRH agonist preparation on plasma gonadotropin and prolactin levels in castrated male rats and on the release of prolactin from ectopic pituitaries.
Sellers KJ; Smith MS; Rojas FJ; Asch RH; Schally AV; Bartke A
Regul Pept; 1986 Oct; 15(3):219-28. PubMed ID: 2947272
[TBL] [Abstract][Full Text] [Related]
19. Prolactin-lowering effect of luteinizing hormone-releasing hormone agonist administration in prolactinoma patients.
Rubio MA; Cabranes JA; Schally AV; Charro AL
J Clin Endocrinol Metab; 1989 Aug; 69(2):444-7. PubMed ID: 2526819
[TBL] [Abstract][Full Text] [Related]
20. Gonadotropin and steroid secretory patterns during chronic treatment with a luteinizing hormone-releasing hormone agonist analog in men.
Evans RM; Doelle GC; Alexander AN; Uderman HD; Rabin D
J Clin Endocrinol Metab; 1984 May; 58(5):862-7. PubMed ID: 6423661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
